Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconRestoration

EP3643309

NINTEDANIB FOR USE IN THE TREATMENT OF SYSTEMIC SCLERODERMA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    21.12.2005
  • EP published:
    3.12.2025
  • EP application number:
    19209457.1
  • Max expiry date:
    20.12.2025
  • Title in English:
    NINTEDANIB FOR USE IN THE TREATMENT OF SYSTEMIC SCLERODERMA
  • Language of the patent:
    English

Timeline

Today
21.12.2005EP application
3.12.2025EP Publication

Owner

  • Name:
    Boehringer Ingelheim International GmbH
  • Address:
    Binger Strasse 173, 55216 Ingelheim am Rhein, DE
  • Name:
    Boehringer Ingelheim Pharma GmbH & Co. KG
  • Address:
    Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

  • Name:
    PARK, John, Edward
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    HECKEL, Armin
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    GRAUERT, Matthias
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    DAHMANN, Georg
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    BRANDL, Trixi
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    CHAUDHARY, Nveed
  • Address:
    55216 INGELHEIM AM RHEIN, DE
  • Name:
    ROTH, Gerald
  • Address:
    55216 INGELHEIM AM RHEIN, DE

Priority

  • Number:
    04030770
  • Date:
    24.12.2004
  • Country:
    EP

Classification

  • Categories:
    A61K 31/404, A61K 31/44, A61K 31/445, A61K 31/495, A61P 17/00, A61P 17/02, A61K 31/4178, A61K 45/06, A61K 31/5377, A61K 31/454, A61K 31/496, A61K 31/4045, A61K 31/551, A61K 9/02, A61K 9/16, A61K 47/38, A61K 47/10, A61K 9/08, A61K 9/20, A61K 9/28, A61K 9/10

Upload documents